Back to search
FDAFDA · Food and drugs·Recall number Z-2285-2012

PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)

Published September 5, 2012 · Recall initiated: August 2, 2012

Summary

FDA records medical device Class III recall Z-2285-2012, published September 5, 2012 and initiated August 2, 2012. Recalling firm: Phadia US Inc; Status: Terminated; Reported quantity: 837 kits (96 assays per kit), total of 80,352 individual assays; Lot: Article Number 15696 Lot number #0067. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Phadia US Inc
Distributor
USA Nationwide.
Lot
Article Number 15696 Lot number #0067
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies) recalled?

Yes. FDA published recall Z-2285-2012 on September 5, 2012. Reported hazard: Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter